 | • レポートコード：MRC2302A086P • 出版社/出版日：360iResearch / 2023年2月1日 • レポート形態：英語、PDF、230ページ • 納品方法：Eメール（受注後3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社発行の当調査レポートでは、2021年に1,041.05百万ドルであった世界のDダイマー検査市場規模が、2022年に1,108.68百万ドルに達し、2027年には1,533.99百万ドルまで年平均6.67％で成長すると予測しています。当レポートは、Dダイマー検査の世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品種類別（分析装置、試薬＆消耗品）分析、検査種類別（臨床検査、ポイントオブケア検査）分析、手法別（酵素免疫測定法 (ELISA)、蛍光イムノアッセイ、ラテックス強化免疫比濁アッセイ）分析、用途別（深部静脈血栓症 (DVT)、播種性血管内凝固症候群 (DIC)、肺塞栓症（PE））分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でまとめております。なお、当書には、Abbott Laboratories Inc.、Apollo Diagnostics、ARUP Laboratories、CTK Biotech, Inc.、Danaher Corporation、Eurolyser Diagnostica GmbH、F. Hoffmann-La Roche AG、Helena Laboratories Corporation、MITSUBISHI CHEMICAL EUROPE GmbH、Quidel Corporation、Radiometer Medical ApSなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のDダイマー検査市場規模：製品種類別 - 分析装置の市場規模 - 試薬＆消耗品の市場規模 ・世界のDダイマー検査市場規模：検査種類別 - 臨床検査の市場規模 - ポイントオブケア検査の市場規模 ・世界のDダイマー検査市場規模：手法別 - 酵素免疫測定法 (ELISA)の市場規模 - 蛍光イムノアッセイの市場規模 - ラテックス強化免疫比濁アッセイの市場規模 ・世界のDダイマー検査市場規模：用途別 - 深部静脈血栓症 (DVT)における市場規模 - 播種性血管内凝固症候群 (DIC)における市場規模 - 肺塞栓症(PE)における市場規模 ・世界のDダイマー検査市場規模：地域別 - 南北アメリカのDダイマー検査市場規模 アメリカのDダイマー検査市場規模 カナダのDダイマー検査市場規模 ブラジルのDダイマー検査市場規模 ... - アジア太平洋のDダイマー検査市場規模 日本のDダイマー検査市場規模 中国のDダイマー検査市場規模 インドのDダイマー検査市場規模 韓国のDダイマー検査市場規模 台湾のDダイマー検査市場規模 ... - ヨーロッパ/中東/アフリカのDダイマー検査市場規模 イギリスのDダイマー検査市場規模 ドイツのDダイマー検査市場規模 インドのDダイマー検査市場規模 フランスのDダイマー検査市場規模 ロシアのDダイマー検査市場規模 ... - その他地域のDダイマー検査市場規模 ・競争状況 ・企業情報 |
The Global D-dimer Testing Market size was estimated at USD 1,041.05 million in 2021 and expected to reach USD 1,108.68 million in 2022, and is projected to grow at a CAGR 6.67% to reach USD 1,533.99 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the D-dimer Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product Type, the market was studied across Analyzers and Reagents & Consumables.
Based on Testing Type, the market was studied across Clinical Laboratory Tests and Point-of-Care Tests.
Based on Method, the market was studied across Enzyme-linked Immunosorbent Assay (ELISA), Fluorescence Immunoassays, and Latex-enhanced Immunoturbidimetric Assays.
Based on Application Type, the market was studied across Deep Vein Thrombosis (DVT), Disseminated Intravascular Coagulation (DIC), and Pulmonary Embolism (PE).
Based on End-User Type, the market was studied across Academic & Research Institutes and Hospitals and Diagnostic Centers.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for D-dimer Testing market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the D-dimer Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global D-dimer Testing Market, including Abbott Laboratories Inc., Apollo Diagnostics, ARUP Laboratories, CTK Biotech, Inc., Danaher Corporation, Eurolyser Diagnostica GmbH, F. Hoffmann-La Roche AG, Helena Laboratories Corporation, MITSUBISHI CHEMICAL EUROPE GmbH, Quidel Corporation, Radiometer Medical ApS, Response Biomedical Corporation, Siemens Medical Solutions Diagnostics Limited, Thermo Fisher Scientific, and Unbound Medicine, Inc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global D-dimer Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global D-dimer Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global D-dimer Testing Market?
4. What is the competitive strategic window for opportunities in the Global D-dimer Testing Market?
5. What are the technology trends and regulatory frameworks in the Global D-dimer Testing Market?
6. What is the market share of the leading vendors in the Global D-dimer Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global D-dimer Testing Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidences of cardiovascular and pulmonary diseases
5.1.1.2. Enlarging the applications of D-dimer tests
5.1.2. Restraints
5.1.2.1. Risk of false-positive results associated with D-dimer testing
5.1.3. Opportunities
5.1.3.1. Rising demand for advanced coagulation testing techniques and cost-effectiveness of the tests
5.1.3.2. Emergence of aptamers for D-dimer testing
5.1.4. Challenges
5.1.4.1. Difficulties relating to the use of D-dimer testing
5.2. Cumulative Impact of COVID-19
6. D-dimer Testing Market, by Product Type
6.1. Introduction
6.2. Analyzers
6.3. Reagents & Consumables
7. D-dimer Testing Market, by Testing Type
7.1. Introduction
7.2. Clinical Laboratory Tests
7.3. Point-of-Care Tests
8. D-dimer Testing Market, by Method
8.1. Introduction
8.2. Enzyme-linked Immunosorbent Assay (ELISA)
8.3. Fluorescence Immunoassays
8.4. Latex-enhanced Immunoturbidimetric Assays
9. D-dimer Testing Market, by Application Type
9.1. Introduction
9.2. Deep Vein Thrombosis (DVT)
9.3. Disseminated Intravascular Coagulation (DIC)
9.4. Pulmonary Embolism (PE)
10. D-dimer Testing Market, by End-User Type
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Hospitals and Diagnostic Centers
11. Americas D-dimer Testing Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific D-dimer Testing Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa D-dimer Testing Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Abbott Laboratories Inc.
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Apollo Diagnostics
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. ARUP Laboratories
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. CTK Biotech, Inc.
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Danaher Corporation
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Eurolyser Diagnostica GmbH
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. F. Hoffmann-La Roche AG
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Helena Laboratories Corporation
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. MITSUBISHI CHEMICAL EUROPE GmbH
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Quidel Corporation
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Radiometer Medical ApS
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Response Biomedical Corporation
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Siemens Medical Solutions Diagnostics Limited
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Thermo Fisher Scientific
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Unbound Medicine, Inc
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing